(PubMed) Huang CH, Kuo CL, Huang CS, et al
This is more than just a new prescription option for Lorene Nikki Rodriguez, MD, AAFP, Dipl
Dapagliflozin for small nerve fibre regeneration in diabetic peripheral neuropathy: a randomised controlled study (DINE)
The goal is to find a safe, tolerable, provider-guided plan that supports weight management while minimizing unnecessary side effects
You may have heard the term glucagon-like peptide 1 before because thats the receptor agonist that other weight loss and diabetes medicines, like Wegovy, target
Treatment that addresses only the volume mechanism (filler alone) misses the cellular mechanism the published literature increasingly suggests is also at play